AD
RACGP

Prof Sean Hood and Mr Bradley Roberts

Pharmacogenetic screening to optimise antidepressant drug therapies in young people

Researchers at the Perron Institute are exploring the benefits of pharmacogenetic testing to optimise antidepressant therapy.

Pharmacogenetic screening to optimise antidepressant drug therapies in young people

Subscribers only

Log in or create a free account to access the full article.

AD